D L Carlson Investment Group Inc Pfizer Inc Transaction History

D L Carlson Investment Group Inc

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	BUY	$39.39 - $51.28 $1,575 - $2,051	40 Added 0.72%	5,571 $227,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $6,179 - $8,066	148 Added 2.75%	5,531 $283,000
Q3 2022 Nov 18, 2022	BUY	$43.76 - $53.42 $32,820 - $40,065	750 Added 16.19%	5,383 $236,000
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $1,349 - $1,599	29 Added 0.63%	4,633 $243,000
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $1,509 - $1,870	33 Added 0.72%	4,604 $238,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $188,873 - $279,973	4,571 New	4,571 $270,000
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $246,540 - $352,253	-9,121 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $1,152 - $1,307	35 Added 0.39%	9,121 $357,000
Q3 2019 Nov 05, 2019	BUY	$32.49 - $42.13 $1,202 - $1,558	37 Added 0.41%	9,086 $326,000
Q2 2019 Aug 19, 2019	SELL	$36.98 - $41.52 $91,303 - $102,512	-2,469 Reduced 21.44%	9,049 $392,000
Q1 2019 May 02, 2019	BUY	$37.5 - $41.2 $1,912 - $2,101	51 Added 0.44%	11,518 $489,000
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $1,769 - $2,017	46 Added 0.4%	11,467 $501,000
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $1,689 - $2,048	49 Added 0.43%	11,421 $503,000
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $1,846 - $1,968	56 Added 0.49%	11,372 $413,000
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $1,723 - $1,999	54 Added 0.48%	11,316 $402,000
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $10,476 - $11,116	315 Added 2.88%	11,262 $408,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $339,357 - $373,840	10,947	10,947 $391,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of D L Carlson Investment Group Inc, based on Form 13F filings with the SEC.

Stay updated on D L Carlson Investment Group Inc with notifications on news.